83 filings
8-K
VOR
Vor Biopharma Inc.
5 Sep 24
Regulation FD Disclosure
4:06pm
8-K
VOR
Vor Biopharma Inc.
30 Aug 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
10-Q/A
2024 Q1
VOR
Vor Biopharma Inc.
Quarterly report (amended)
8 Aug 24
4:13pm
10-Q
2024 Q2
VOR
Vor Biopharma Inc.
Quarterly report
8 Aug 24
4:01pm
8-K
VOR
Vor Biopharma Inc.
10 Jun 24
Departure of Directors or Certain Officers
4:05pm
8-K
z87r4q4ut 0f697r20s
28 May 24
Departure of Directors or Certain Officers
4:54pm
DEFA14A
27k4exu3mcy30vpoknc
2 May 24
Additional proxy soliciting materials
4:08pm
8-K
9vjos2r lt
2 May 24
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
4:07pm
ARS
10dp0ls
9 Apr 24
Annual report to shareholders
4:10pm
DEFA14A
i9gfe6wy
9 Apr 24
Additional proxy soliciting materials
4:07pm
S-8
0hmw5oa zcuqz2ltt2m
20 Mar 24
Registration of securities for employees
6:20pm
8-K
3w0s4lg4d2 q6en
5 Jan 24
Other Events
5:03pm
8-K
i4tg p17k97twvwjxv9
2 Nov 23
Multiple Clinical and Preclinical Presentations at ASH 2023
9:10am
S-8
7ad3ucd55 aqw
30 Aug 23
Registration of securities for employees
4:51pm
8-K
068ok5c3z z1u0m
9 Jun 23
Regulation FD Disclosure
7:41am